Thomas Koudstaal
Overview
Explore the profile of Thomas Koudstaal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moor C, Gur-Demirel Y, Koudstaal T, Miedema J
Chest
. 2025 Jan;
167(1):e34-e35.
PMID: 39794093
No abstract available.
2.
Moor C, Gur-Demirel Y, Koudstaal T, Miedema J
Chest
. 2024 Aug;
166(6):1473-1475.
PMID: 39134142
No abstract available.
3.
Koudstaal T, den Bosch T, Bergen I, Lila K, Bresser P, Bogaard H, et al.
Eur J Immunol
. 2024 Apr;
54(6):e2350670.
PMID: 38593342
Chronic thromboembolic pulmonary hypertension (CTEPH) is a debilitating disease characterized by thrombotic occlusion of pulmonary arteries and vasculopathy, leading to increased pulmonary vascular resistance and progressive right-sided heart failure. Thrombotic...
4.
Veen K, Koudstaal T, Hendriks P, Takkenberg J, Boomars K, van den Bosch A
Int J Cardiol Heart Vasc
. 2024 Feb;
51:101342.
PMID: 38389829
Aims: The prognostic value of functional tricuspid valve regurgitation (TR) in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (CTEPH) remains undetermined. This study primarily aims to quantify...
5.
Koudstaal T, Funke-Chambour M, Kreuter M, Molyneaux P, Wijsenbeek M
Trends Mol Med
. 2023 Sep;
29(12):1076-1087.
PMID: 37716906
Pulmonary fibrosis (PF) encompasses a spectrum of chronic lung diseases that progressively impact the interstitium, resulting in compromised gas exchange, breathlessness, diminished quality of life (QoL), and ultimately respiratory failure...
6.
Koudstaal T, Wijsenbeek M
Presse Med
. 2023 May;
52(3):104166.
PMID: 37156412
Idiopathic pulmonary fibrosis (IPF) is a progressive devastating lung disease with substantial morbidity. It is associated with cough, dyspnea and impaired quality of life. If left untreated, IPF has a...
7.
8.
Cai Z, Tian S, Klein T, Tu L, Geenen L, Koudstaal T, et al.
Sci Rep
. 2022 Jul;
12(1):12326.
PMID: 35853948
Activation of the kynurenine pathway (KP) has been reported in patients with pulmonary arterial hypertension (PAH) undergoing PAH therapy. We aimed to determine KP-metabolism in treatment-naïve PAH patients, investigate its...
9.
van Uden D, Koudstaal T, van Hulst J, Vink M, van Nimwegen M, van den Toorn L, et al.
Int J Mol Sci
. 2022 Jun;
23(12).
PMID: 35742956
Pulmonary arterial hypertension (PAH) is rare disease that is categorized as idiopathic (IPAH) when no underlying cause can be identified. Lungs of most patients with IPAH contain increased numbers of...
10.
van Uden D, Koudstaal T, van Hulst J, van den Bosch T, Vink M, Bergen I, et al.
Front Immunol
. 2022 May;
13:861450.
PMID: 35572511
Introduction: Previous studies have shown an increase of T cells and chemokines in vascular lesions of patients with chronic thromboembolic pulmonary hypertension (CTEPH). However, detailed characterization of these T cells...